Astrana Health (ASTH) Common Equity (2011 - 2026)

Astrana Health has disclosed Common Equity across 16 years of filings, most recently posting $815.2 million for Q1 2026.

• Common Equity for Q1 2026 came in at $815.2 million, up 8.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $815.2 million (up 8.63% YoY), and the FY2025 annual result was $779.3 million, up 8.73% from the prior year.
• Common Equity came in at $815.2 million for Q1 2026 at Astrana Health, up from $779.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $815.2 million in Q1 2026 to a low of $472.6 million in Q1 2022.
• The 5-year median for Common Equity is $658.0 million (2024), against an average of $647.6 million.
• Across the five-year window, Common Equity soared 36.19% in 2022 and gained 8.63% in 2026, its largest moves.
• Astrana Health's Common Equity stood at $544.3 million in 2022, then increased by 13.29% to $616.7 million in 2023, then gained by 16.23% to $716.7 million in 2024, then grew by 8.73% to $779.3 million in 2025, then gained by 4.61% to $815.2 million in 2026.
• The last three Common Equity figures came in at $815.2 million (Q1 2026), $779.3 million (Q4 2025), and $789.1 million (Q3 2025), per Business Quant data.